Expression of the stress-associated protein p8 is a requisite for tumor development

Review Article

Abstract

We identified a new gene, called p8, because its expression was strongly induced during the acute phase of pancreatitis. Further experiments have shown that p8 mRNA is activated in response to several stresses and that its activation is not restricted to pancreatic cells. p8 is a nuclear protein and biochemical and biophysical studies have shown that p8 was very similar in many structural aspects to the HMG proteins, although sharing only low amino acid sequence homology. Also, p8 was found overexpressed in many human cancers. Therefore, we wondered whether the p8-mediated response to cellular stress was necessary for tumor establishment. Subcutaneous or intraperitoneal injections of transformed p8-expressing fibroblasts led to tumor formation in nude mice, but no tumor was observed with transformed p8-deficient cells. Restoring p8 expression in transformed p8-deficient fibroblasts led to tumor formation, demonstrating that p8 expression is crucial for tumor development and suggesting that the stress-response mechanisms governed by p8 are required for tumor establishment.

Key Words

Stress proteins cellular stress p8 knockout mice tumor progression 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dusetti NJ, Tomasini R, Azizi A, et al. Expression profiling in pancreas during the acute phase of pancreatitis using cDNA microarrays. Biochem Biophys Res Commun 2000;277:660–667.PubMedCrossRefGoogle Scholar
  2. 2.
    Mallo GV, Fiedler F, Calvo EL, et al. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J Biol Chem 1997;272:32,360–32,369.CrossRefGoogle Scholar
  3. 3.
    Jiang YF, Vaccaro MI, Fiedler F, et al. Lipopolysaccharides induce p8 mRNA expression in vivo and in vitro. Biochem Biophys Res Commun 1999;260:686–690.PubMedCrossRefGoogle Scholar
  4. 4.
    Garcia-Montero A, Vasseur S, Mallo GV, et al. Expression of the stress-induced p8 mRNA is transiently activated after culture medium change. Eur J Cell Biol 2001;80:720–725.PubMedCrossRefGoogle Scholar
  5. 5.
    Vasseur S, Mallo GV, Fiedler F, et al. Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur J Biochem 1999;259:670–675.PubMedCrossRefGoogle Scholar
  6. 6.
    Vasseur S, Mallo GV, Garcia-Montero A, et al. Structural and functional characterization of the mouse p8 gene: promotion of transcription by the CAAT-enhancer binding protein alpha (C/EBPalpha) and C/EBPbeta trans-acting factors involves a C/EBP cis-acting element and other regions of the promoter. Biochem J 1999;343:377–383.PubMedCrossRefGoogle Scholar
  7. 7.
    Igarashi T, Kuroda H, Takahashi S, et al. Cloning and characterization of the Xenopus laevis p8 gene. Develop Growth Differ 2001;43:693–698.CrossRefGoogle Scholar
  8. 8.
    Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acids Res Mol Biol 1996;54:35–100.CrossRefGoogle Scholar
  9. 9.
    Bergel M, Herrera JE, Thatcher BJ, et al. Acetylation of novel sites in the nucleosomal binding domain of chromosomal protein HMG-14 by p300 alters its interaction with nucleosomes. J Biol Chem 2000;275:11,514–11,520.CrossRefGoogle Scholar
  10. 10.
    Encinar JA, Mallo GV, Mizyrycki C, et al. Human p8 is a HMG-I/Y-like protein with DNA binding activity enhanced by phosphorylation. J Biol Chem 2001;276:2742–2751.PubMedCrossRefGoogle Scholar
  11. 11.
    Croniger C, Leahy P, Reshef L, et al. C/EBP and the control of phosphoenolpyruvate carboxykinase gene transcription in the liver. J Biol Chem 1998;273:31,629–31,632.CrossRefGoogle Scholar
  12. 12.
    Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998;273:28,545–28,548.CrossRefGoogle Scholar
  13. 13.
    Fidler IJ. Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst 1995;87:1588–1592.PubMedCrossRefGoogle Scholar
  14. 14.
    Uhr JW, Scheuermann RH, Street NE, et al. Cancer dormancy: opportunities for new therapeutic approaches. Nat Med 1997;3:505–509.PubMedCrossRefGoogle Scholar
  15. 15.
    Holmgren L, O’Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149–153.PubMedCrossRefGoogle Scholar
  16. 16.
    Luzzi KJ, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998;153:865–873.PubMedGoogle Scholar
  17. 17.
    Kerbel RS: Significance of tumor-host interactions in cancer growth and metastases. Cancer Metastasis Rev 1995;14:259–262.PubMedCrossRefGoogle Scholar
  18. 18.
    Su SB, Motoo Y, Iovanna JL, et al. Expression of p8 in human pancreatic cancer. Clin Cancer Res 2001;7:309–313.PubMedGoogle Scholar
  19. 19.
    Su SB, Motoo Y, Iovanna JL, et al. Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer. Clin Cancer Res 2001;7:1320–1324.PubMedGoogle Scholar
  20. 20.
    Ree AH, Pacheco MM, Tvermyr M, et al. Expression of a novel factor, com1, in early tumor progression of breast cancer. Clin Cancer Res 2000;6:1778–1783.PubMedGoogle Scholar
  21. 21.
    Ree AH, Tvermyr M, Engebraaten O, et al. Expression of a novel factor in human breast cancer cells with metastatic potential. Cancer Res 1999;59:4675–4680.PubMedGoogle Scholar
  22. 22.
    Vasseur S, Hoffmeister A, Garcia S, et al. p8 is critical for tumor development induced by rasV12 mutated protein and E1A oncogene. EMBO Rep 2002;3:165–170.PubMedCrossRefGoogle Scholar
  23. 23.
    Garcia-Montero AC, Vasseur S, Giono LE, et al. Transforming growth factor beta-1 enhances Smad transcriptional activity through activation of p8 gene expression. Biochem J 2001;357:249–253.PubMedCrossRefGoogle Scholar
  24. 24.
    Himes SR, Reeves R, Attema J, et al. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation. J Immunol 2000;164:3157–3168.PubMedGoogle Scholar
  25. 25.
    Bonnefoy E, Bandu MT, Doly J. Specific binding of high-mobility-group I (HMGI) protein and histone H1 to the upstream AT-rich region of the murine beta interferon promoter: HMGI protein acts as a potential anti-repressor of the promoter. Mol Cell Biol 1999; 19: 2803–2816.PubMedGoogle Scholar
  26. 26.
    Mantovani F, Covaceuszach S, Rustighi A, et al. NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C. Nucleic Acids Res 1998;26:1433–1439.PubMedCrossRefGoogle Scholar
  27. 27.
    Arlotta P, Rustighi A, Mantovani F, et al. High mobility group I proteins interfere with the homeodomains binding to DNA. J Biol Chem 1997;272:29,904–29,910.CrossRefGoogle Scholar
  28. 28.
    Wood LD, Farmer AA, Richmond A. HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Res 1995;23:4210–4219.PubMedCrossRefGoogle Scholar
  29. 29.
    Utz PJ, Anderson P. Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Differ 2000;7:589–602.PubMedCrossRefGoogle Scholar
  30. 30.
    Wang E, Marcotte R, Petroulakis E. Signaling pathway for apoptosis: a racetrack for life or death. J Cell Biochem 1999;32–33:95–102.CrossRefGoogle Scholar
  31. 31.
    Vasseur S, Hoffmeister A, Garcia-Montero A, et al. p8-deficient fibroblasts growth more rapidly and are more resistant to the apoptosis induced by adriamycin. Oncogene 2002;21:1685–1694.PubMedCrossRefGoogle Scholar
  32. 32.
    Amundson SA, Myers TG, Fornace AJ. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 1998;17:3287–3299.PubMedCrossRefGoogle Scholar
  33. 33.
    Colman MS, Afshari CA, Barrett JC. Regulation of p53 stability and activity in response to genotoxic stress. Mutat Res 2000;462:179–188.PubMedCrossRefGoogle Scholar
  34. 34.
    Farmer G, Colgan J, Nakatani Y, et al. Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo. Mol Cell Biol 1996;16:4295–4304.PubMedGoogle Scholar
  35. 35.
    Martin DW, Munoz RM, Subler MA, et al. p53 binds to the TATA-binding protein-TATA complex. J Biol Chem 1993;268:13,062–13,067.Google Scholar
  36. 36.
    Ragimov N, Krauskopf A, Navot N, et al. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene 1993;8:1183–1193.PubMedGoogle Scholar
  37. 37.
    Seto E, Usheva A, Zambetti GP, et al. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 1992;89:12,028–12,032.CrossRefGoogle Scholar
  38. 38.
    Serrano M, Lin AW, McCurrach ME, et al. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593–602.PubMedCrossRefGoogle Scholar
  39. 39.
    Lin AW, Barradas M, Stone JC, et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998;12:3008–3019.PubMedCrossRefGoogle Scholar
  40. 40.
    Vousden KH: p53: death star. Cell 2000;103:691–694.PubMedCrossRefGoogle Scholar
  41. 41.
    Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307–310.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2002

Authors and Affiliations

  1. 1.Parc Scientifique et Technologique de LuminyCentre de Recherche INSERM, EMI0116MarseilleFrance

Personalised recommendations